EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting disease‐specific survival in patients undergoing active surveillance for papillary thyroid carcinoma

Stanton Nielsen iD, Kristine Kuchta, Grace Huang, Samuel Zuber, Simon Holoubek, Amanda Karcioglu, Amna Khokar, Richard Prinz, Tricia Moo-Young

World Journal of Surgery · 2025

DOI: 10.1002/wjs.12434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Surgery, 2025. Verfasst von Stanton Nielsen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, NorthShore University HealthSystem, Evanston, IL, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Cancer, Papillary, Watchful Waiting. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

American Thyroid Association guidelines support active surveillance (AS) for low‐risk papillary thyroid cancer (PTC). We developed a calculator to aid patient selection.

Methods

From 2004 to 2020, 148,904 PTC patients were selected from the surveillance, epidemiology, and end results (SEER) database. Univariable and multivariable analysis evaluated patient and treatment characteristics. Patients were randomly allocated into training (80%) or validation sets (20%). Coefficients generated a mathematical model to predict 5‐ and 10‐year disease‐specific survival (DSS).

Results

The mean DSS was 15.5 years with a 5‐ and 10‐year DSS of 99.3% and 98.6%, respectively. Age, sex, race, median household income (MHI), tumor size, and nodal status were significant on multivariable analysis ( p ≤ 0.05) and included variables in our calculator. 2404 patients underwent non‐operative management (NOM) and were more likely older, male, higher MHI, larger tumor size, and less nodal positivity. Area under the curve (AUC) for 5‐ and 10‐year DSS were 0.83 and 0.81, respectively, for the training set and 0.81 and 0.79, respectively, for the validation set. Example 65‐year‐old White female with a 0.8 cm PTC, cN0 with a MHI ≥ $75,000, had a 10‐year predicted DSS was 95.6% with NOM and 99.3% with surgery. Alternatively, changing the patient's race to Hispanic, the 10‐year predicted DSS was 94.1% with NOM and 99.0% with surgery.

Conclusions

As awareness of AS for PTC expands, it is important to consider objective data to guide informed decision making. This validated calculator is a useful tool to predict DSS for patients considering AS for PTC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroid Cancer, PapillaryWatchful WaitingHumansMaleFemaleMiddle AgedAdultSEER ProgramAgedPatient Selection

Stichwörter der Autor:innen

endocrinehead and neckoncologythyroid

Autor:innen und Institutionen

  • Department of Surgery, NorthShore University HealthSystem, Evanston, IL, USA.
  • The University of Chicago Medical Center Chicago, Chicago, IL, USA.
  • Department of Surgery, University of Wisconsin-Madison, Madison, WI, USA.
  • Department of Surgery, John H. Stroger Jr, Hospital of Cook County, Chicago, IL, USA.

ORCID-Profile: Stanton Nielsen

Zitieren

APA

Nielsen, S., Kuchta, K., Huang, G., Zuber, S., Holoubek, S., Karcioglu, A., Khokar, A., Prinz, R., & Moo-Young, T. (2025). Predicting disease‐specific survival in patients undergoing active surveillance for papillary thyroid carcinoma. World Journal of Surgery. https://doi.org/10.1002/wjs.12434

Vancouver

Nielsen S, Kuchta K, Huang G, Zuber S, Holoubek S, Karcioglu A, et al. Predicting disease‐specific survival in patients undergoing active surveillance for papillary thyroid carcinoma. World Journal of Surgery. 2025. doi:10.1002/wjs.12434

BibTeX
@article{Nielsen2025,
  author = {Nielsen, Stanton and Kuchta, Kristine and Huang, Grace and Zuber, Samuel and Holoubek, Simon and Karcioglu, Amanda and Khokar, Amna and Prinz, Richard and Moo-Young, Tricia},
  title = {Predicting disease‐specific survival in patients undergoing active surveillance for papillary thyroid carcinoma},
  journal = {World Journal of Surgery},
  year = {2025},
  doi = {10.1002/wjs.12434}
}
Kostenlos starten →